Cystic fibrosis with pulmonary manifestations
Billable / specificHCC V28 277
E84.0 is a billable, specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes in FY2027.
Inclusion terms
Includes (from E84)
- mucoviscidosis
- Note: All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
Excludes1
Not coded here — never report together with this code.
- transitory endocrine and metabolic disorders specific to newborn (P70-P74) (from E84)
- androgen insensitivity syndrome (E34.5-) (from E84)
- congenital adrenal hyperplasia (E25.0) (from E84)
- hemolytic anemias attributable to enzyme disorders (D55.-) (from E84)
- Marfan syndrome (Q87.4-) (from E84)
- 5-alpha-reductase deficiency (E29.1) (from E84)
Excludes2
Not included here — may be reported together when both conditions exist.
Use additional code
Add a code to identify the following, if applicable.
- code to identify any infectious organism present, such as:
- Pseudomonas (B96.5)
Code also
An additional code may be needed.
Also known as
- Fibrosis, fibrotic, cystic, with pulmonary manifestations
Parent code
- E84Cystic fibrosisHeader